Evidence map›Paper›PMID 37899523›Full record

ArticleKorean journal of radiology2023

Liming Xiao, Shupeng Yu, Weina Xu, Yishan Sun, Jun Xin

Open access · hybridAbstract read
In one paragraph

Article in Korean journal of radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. New Oncologic Imaging Section in theKorean journal of radiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Liming XiaoDepartment of Nuclear Medicine, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.ORCID 0009-0002-1227-6162
Shupeng YuDepartment of Nuclear Medicine, Shengjing Hospital of China Medical University, Shenyang, China.ORCID 0009-0004-1327-0306
Weina XuDepartment of Nuclear Medicine, Shengjing Hospital of China Medical University, Shenyang, China.ORCID 0009-0006-1990-3930
Yishan SunDepartment of Nuclear Medicine, Shengjing Hospital of China Medical University, Shenyang, China.ORCID 0000-0001-7891-2104
Jun XinDepartment of Nuclear Medicine, Shengjing Hospital of China Medical University, Shenyang, China. xinj@sj-hospital.org.ORCID 0000-0001-5660-6368
China Medical University · CNUniversity of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate MATERIALS AND

methodsWe prospectively enrolled 26 patients with primary malignant lung tumors who underwent

resultsTotal 42 stations had metastatic lymph nodes and 136 stations had benign lymph nodes. The differences between metastatic and benign lymph nodes in the visual qualitative and semiquantitative analyses of

conclusion

Indexed as

Lung NeoplasmsPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18HumansLymphatic MetastasisRadiopharmaceuticalsTomography, Emission-Computed, Single-PhotonFluorodeoxyglucose F18RadiopharmaceuticalsLung cancerLymph node metastasisPET/CTSPECT/CT

Identifiers

PMID37899523
PMCPMC10613846
OpenAlexW4387767617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.